Pasar al contenido principal

ESTRATEGIAS DE TERAPIA GENICA PARA CONTROLAR LA INFECCION POR LOS VIRUS DE LA HEPATITIS B Y DELTA BASADA EN EL ESTUDIO DE LAS CUASIESPECIES VIRALES POR SECUENCIACION MASIVA

PID2021-126447OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genotyping Hepatitis B virus by Next-Generation Sequencing, Detection of Mixed Infections and Analysis of Sequence Conservation

  • Dopico, Eva|||0000-0002-5306-3035
  • Vila, Marta|||0000-0001-9303-5189
  • Tabernero, David|||0000-0002-1146-4084
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Pacín Ruiz, Beatriz|||0000-0001-8718-6589
  • Guerrero, Laura|||0000-0003-1978-9067
  • Ubillos, Itziar|||0000-0002-0993-0058
  • Martínez, Miguel J.|||0000-0002-0682-1075
  • Costa, Josep|||0000-0001-7978-0748
  • Quer, Josep|||0000-0003-0014-084X
  • Pérez Garreta, Javier
  • González Sánchez, Alejandra|||0000-0002-1809-3415
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Buti, Maria|||0000-0002-0732-3078
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Cortese, Maria Francesca|||0000-0002-4318-532X
Our aim was to develop an accurate, highly sensitive method for HBV genotype determination and detection of genotype mixtures. We examined the preS and 5' end of the HBV X gene (5X) regions of the HBV genome using next-generation sequencing (NGS). The 1852 haplotypes obtained were subjected to genotyping via the Distance-Based discrimination method (DB Rule) using two sets of 95 reference sequences of genotypes A-H. In clinical samples from 125 patients, the main genotypes were A, D, F and H in Caucasian, B and C in Asian and A and E in Sub-Saharan patients. Genotype mixtures were identified in 28 (22.40%) cases, and potential intergenotypic recombination was observed in 29 (23.20%) cases. Furthermore, we evaluated sequence conservation among haplotypes classified into genotypes A, C, D, and E by computing the information content. The preS haplotypes exhibited limited shared conserved regions, whereas the 5X haplotypes revealed two groups of conserved regions across the genotypes assessed. In conclusion, we developed an NGS-based HBV genotyping method utilizing the DB Rule for genotype classification. We identified two regions conserved across different genotypes at 5X, offering promising targets for RNA interference-based antiviral therapies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2, Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Campos, Carolina|||0000-0002-0132-7027
  • Ibañez Lligoña, Marta|||0000-0003-3428-2168
  • Colomer Castell, Sergi|||0000-0002-0307-7455
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Garcia-Cehic, D.|||0000-0002-0009-038X
  • Andrés, Cristina|||0000-0002-3200-0895
  • Piñana, Maria|||0000-0002-4766-2613
  • González Sánchez, Alejandra|||0000-0002-1809-3415
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Esperalba, Juliana|||0000-0003-1326-1341
  • Saubi, Narcis|||0000-0001-5493-1044
  • Cortese, Maria Francesca|||0000-0002-4318-532X
  • Tabernero, David|||0000-0002-1146-4084
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Kakze-van der Honing, Renate W.
  • Kampfraath, Andries A.
  • Vergara-Alert, Júlia|||0000-0001-7484-444X
  • Segalés Coma, Joaquim|||0000-0002-1539-7261
  • van der Poel, Wim H. M.
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
  • Quer, Josep|||0000-0003-0014-084X
SARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

  • Llorens-Revull, Meritxell|||0000-0002-8671-8907
  • Martínez-González, Brenda|||0000-0002-4482-5181
  • Quer, Josep|||0000-0003-0014-084X
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Núñez-Moreno, Gonzalo|||0000-0001-5982-570X
  • Minguez, Pablo|||0000-0003-4099-9421
  • Burgui, Idoia
  • Ramos-Ruiz, Ricardo|||0000-0002-6331-9786
  • Soria Benito, María Eugenia|||0000-0002-4719-3351
  • Rico, Angie
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Sauleda, Silvia|||0000-0001-7343-9557
  • Piron, Maria|||0000-0001-6858-9374
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Camós Anguila, Sílvia|||0000-0002-0478-8494
  • Domingo, Esteban
  • Bes, Marta|||0000-0001-6103-072X
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Costafreda Salvany, Maria Isabel|||0000-0002-3114-3034
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments

  • Colomer Castell, Sergi|||0000-0002-0307-7455
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Garcia-Cehic, D.|||0000-0002-0009-038X
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Buti, Maria|||0000-0002-0732-3078
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Vico-Romero, Judit|||0000-0003-2461-4317
  • Campos, Carolina|||0000-0002-0132-7027
  • Ibañez Lligoña, Marta|||0000-0003-3428-2168
  • Adombi, Caroline Melanie|||0000-0001-9739-9166
  • Cortese, Maria Francesca|||0000-0002-4318-532X
  • Tabernero, David|||0000-0002-1146-4084
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Quer, Josep|||0000-0003-0014-084X
Here, we report the in-host hepatitis E virus (HEV) quasispecies evolution in a chronically infected patient who was treated with three different regimens of ribavirin (RBV) for nearly 6 years. Sequential plasma samples were collected at different time points and subjected to RNA extraction and deep sequencing using the MiSeq Illumina platforms. Specifically, we RT-PCR amplified a single amplicon from the core region located in the open-reading frame 2 (ORF2). At the nucleotide level (genotype), our analysis showed an increase in the number of rare haplotypes and a drastic reduction in the frequency of the master (most represented) sequence during the period when the virus was found to be insensitive to RBV treatment. Contrarily, at the amino acid level (phenotype), our study revealed conservation of the amino acids, which is represented by a high prevalence of the master sequence. Our findings suggest that using mutagenic antivirals concomitant with high viral loads can lead to the selection and proliferation of a rich set of synonymous haplotypes that express the same phenotype. This can also lead to the selection and proliferation of conservative substitutions that express fitness-enhanced phenotypes. These results have important clinical implications, as they suggest that using mutagenic agents as a monotherapy treatment regimen in the absence of sufficiently effective viral inhibitors can result in diversification and proliferation of a highly diverse quasispecies resistant to further treatment. Therefore, such approaches should be avoided whenever possible.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Campos, Carolina
  • Ibañez-Lligoña, Marta
  • Colomer‑Castell, Sergi
  • Gregori, Josep
  • Garcia‑Cehic, Damir
  • Andrés, Cristina
  • Piñana, Maria
  • González‑Sánchez, Alejandra
  • Rando‑Segura, Ariadna
  • Esperalba, Juliana
  • Saubí, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Rodriguez-Frias, Francisco
  • Ferrer, Roser
  • Esteban, Juan Ignacio
  • Kakze-van der Honing, Renate W.
  • Kampfraath, Andries A.
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • van der Poel, Wim H. M.
  • Pumarola, Tomàs
  • Antón, Andrés
  • Quer, Josep
SARS‐CoV‐2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep‐sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS‐CoV‐2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by Spanish Ministry of Education, Centro para el Desarrollo Tecnológico Industrial (CDTI), Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness, Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, 'la Caixa' Foundation, Consorcio Centro de Investigación Biomédica en Red (CIBER), and Early Response and Rapid Action Zoonotic Emergencies Program (ERRAZE)., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

  • Llorens-Revull, Meritxell
  • Martínez-González, Brenda
  • Quer, Josep
  • Esteban, Juan Ignacio
  • Núñez-Moreno, Gonzalo
  • Mínguez, Pablo
  • Burgui, Idoia
  • Ramos-Ruiz, Ricardo
  • Soria, María Eugenia
  • Rico, Angie
  • Riveiro-Barciela, Mar
  • Sauleda, Silvia
  • Piron, María
  • Corrales, Irene
  • Borràs, Francesc E.
  • Rodríguez-Frías, Francisco
  • Rando, Ariadna
  • Ramírez-Serra, Clara
  • Camós, Silvia
  • Domingo, Esteban
  • Bes, Marta
  • Perales, Celia
  • Costafreda, María Isabel
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples., This study was funded by Instituto de Salud Carlos III, co-financed by the European Regional Development Fund (ERDF): grant numbers PI18/00210, PI19/00301, PI19/00533, PI21/00139, and PI22/00258; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297. The work at CBMSO was supported by grants SAF2014-52400-R from Ministerio de Economía y Competitividad (MINECO), SAF2017-87846-R and BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), project 525/C/2021 from Fundaciό La Maratό de TV3, PID2020-113888RB-I00, PID2021-126447OB-I00, and 202220I116 from Ministerio de Ciencia e Innovaciόn (MICINN), S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER), and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission–NextGenerationEU (regulation EU 2020/2094) through the CSIC’s Global Health Platform (PTI Salud Global). C.P. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121 and CPII19/00001), co-financed by the European Regional Development Fund (ERDF). M.LL. is a recipient of a pre-doctoral fellowship from Instituto de Salud Carlos III (FI20/00313), co-financed by the European Regional Development Fund (ERDF). B.M.-G. is supported by pre-doctoral contract PFIS FI19/00119 from ISCIII, co-financed by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro”. CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by ISCIII. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments

  • Vico-Romero, Judit
  • Campos, Carolina
  • Cortese, Maria Francesca
  • Colomer-Castell, Sergi
  • Gregori Font, Josep
  • Garcia-Cehic, Damir
  • Riveiro-Barciela, Mar
  • Rando Segura, Ariadna
  • Ibañez Lligoña, Marta
  • ADOMBI, Caroline Mélanie
  • Tabernero, David
  • Esteban Mur, Juan Ignacio
  • RODRIGUEZ-FRIAS, FRANCISCO
  • QUER, JOSEP
  • Buti Ferret, Maria
Deep sequencing; Mutagens; Quasispecies, Seqüenciació profunda; Mutàgens; Quasiespècie, Secuenciación profunda; Mutágenos; Cuasiespecie, Here, we report the in-host hepatitis E virus (HEV) quasispecies evolution in a chronically infected patient who was treated with three different regimens of ribavirin (RBV) for nearly 6 years. Sequential plasma samples were collected at different time points and subjected to RNA extraction and deep sequencing using the MiSeq Illumina platforms. Specifically, we RT-PCR amplified a single amplicon from the core region located in the open-reading frame 2 (ORF2). At the nucleotide level (genotype), our analysis showed an increase in the number of rare haplotypes and a drastic reduction in the frequency of the master (most represented) sequence during the period when the virus was found to be insensitive to RBV treatment. Contrarily, at the amino acid level (phenotype), our study revealed conservation of the amino acids, which is represented by a high prevalence of the master sequence. Our findings suggest that using mutagenic antivirals concomitant with high viral loads can lead to the selection and proliferation of a rich set of synonymous haplotypes that express the same phenotype. This can also lead to the selection and proliferation of conservative substitutions that express fitness-enhanced phenotypes. These results have important clinical implications, as they suggest that using mutagenic agents as a monotherapy treatment regimen in the absence of sufficiently effective viral inhibitors can result in diversification and proliferation of a highly diverse quasispecies resistant to further treatment. Therefore, such approaches should be avoided whenever possible., This study was partially supported by Plan Estratègic de Recerca i Innovació en Salut (PERIS)—Direcció General de Recerca i Innovació en Salut (DGRIS), Catalan Health Ministry, Generalitat de Catalunya; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297, Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Projects PI19/00301 and PI22/00258 funded by Instituto de Salud Carlos III (ISCIII) and cofounded by the European Union; and Gilead’s biomedical research project GLD21/00006. S.C.-C has received support from Spanish Ministry of Education, grant FPU21/04150. M.I.-L. received the support of a fellowship from the “la Caixa” Foundation (ID 100010434), whose code is “LCF/BQ/DR23/12000020”.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence Conservation

  • Dopico, Eva
  • Vila Salvador, Marta
  • Pacin Ruiz, Beatriz
  • Pérez Garreta, Javier
  • Buti Ferret, Maria
  • Tabernero, David
  • Gregori Font, Josep
  • Rando Segura, Ariadna
  • QUER, JOSEP
  • González-Sánchez, Alejandra
  • Pumarola Suñe, Tomàs
  • Riveiro-Barciela, Mar
  • Ferrer Costa, Roser
  • RODRIGUEZ-FRIAS, FRANCISCO
  • Cortese, Maria Francesca
  • Antón Pagarolas, Andrés
RNA interference; Hepatitis B X gene; Next-generation sequencing, Interferència d'ARN; Gen de l'hepatitis BX; Seqüenciació de nova generació, Interferencia de ARN; Gen de la hepatitis BX; Secuenciación de nueva generación, Our aim was to develop an accurate, highly sensitive method for HBV genotype determination and detection of genotype mixtures. We examined the preS and 5' end of the HBV X gene (5X) regions of the HBV genome using next-generation sequencing (NGS). The 1852 haplotypes obtained were subjected to genotyping via the Distance-Based discrimination method (DB Rule) using two sets of 95 reference sequences of genotypes A-H. In clinical samples from 125 patients, the main genotypes were A, D, F and H in Caucasian, B and C in Asian and A and E in Sub-Saharan patients. Genotype mixtures were identified in 28 (22.40%) cases, and potential intergenotypic recombination was observed in 29 (23.20%) cases. Furthermore, we evaluated sequence conservation among haplotypes classified into genotypes A, C, D, and E by computing the information content. The preS haplotypes exhibited limited shared conserved regions, whereas the 5X haplotypes revealed two groups of conserved regions across the genotypes assessed. In conclusion, we developed an NGS-based HBV genotyping method utilizing the DB Rule for genotype classification. We identified two regions conserved across different genotypes at 5X, offering promising targets for RNA interference-based antiviral therapies., This research was funded by the grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297; Projects PI19/00301 and PI22/00258 funded by Instituto de Salud Carlos III (ISCIII) and cofounded by the European Union.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications

  • Gregori Font, Josep
  • Colomer-Castell, Sergi
  • Ibañez Lligoña, Marta
  • Garcia-Cehic, Damir
  • Campos, Carolina
  • Riveiro-Barciela, Mar
  • Piñana, María
  • González-Sánchez, Alejandra
  • RODRIGUEZ-FRIAS, FRANCISCO
  • Cortese, Maria Francesca
  • Tabernero, David
  • Rando Segura, Ariadna
  • Pumarola Suñe, Tomàs
  • Esteban Mur, Juan Ignacio
  • QUER, JOSEP
  • Buti Ferret, Maria
  • Antón Pagarolas, Andrés
  • Andrés Vergés, Cristina
Cuasiespecies; Mutágenos; Mutaciones, Quasispecies; Mutagens; Mutations, Quasiespècie; Mutàgens; Mutacions, The repeated failure to treat patients chronically infected with hepatitis E (HEV) and C (HCV) viruses, despite the absence of resistance-associated substitutions (RAS), particularly in response to prolonged treatments with the mutagenic agents of HEV, suggests that quasispecies structure may play a crucial role beyond single point mutations. Quasispecies structured in a flat-like manner (referred to as flat-like) are considered to possess high average fitness, occupy a significant fraction of the functional genetic space of the virus, and exhibit a high capacity to evade specific or mutagenic treatments. In this paper, we studied HEV and HCV samples using high-depth next-generation sequencing (NGS), with indices scoring the different properties describing flat-like quasispecies. The significance of these indices was demonstrated by comparing the values obtained from these samples with those from acute infections caused by respiratory viruses (betacoronaviruses, enterovirus, respiratory syncytial viruses, and metapneumovirus). Our results revealed that flat-like quasispecies in HEV and HCV chronic infections without RAS are characterized by numerous low-frequency haplotypes with no dominant one. Surprisingly, these low-frequency haplotypes (at the nucleotide level) exhibited a high level of synonymity, resulting in much lower diversity at the phenotypic level. Currently, clinical approaches for managing flat-like quasispecies are lacking. Here, we propose methods to identifying flat-like quasispecies, which represents an essential initial step towards exploring alternative treatment protocols for viruses resistant to conventional therapies., This study was partially supported by Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297; Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Fondo de Investigación Sanitaria, Ministerio Español de Economía y Competitividad (grants FIS PI19/00301, PI22/00258, PI22/00023 and PI23/01065); CIBER—Consorcio Centro de Investigación Biomédica en Red—(CIBERINFEC, ISCIII—CIBER de Enfermedades Infecciosas & CIBEREHD, ISCIII. CIBER de Enfermedades Hepáticas y Digestivas), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea—NextGenerationEU; S.C.-C received support from the Spanish Ministry of Education grant FPU21/04150. M.I.-L. received the support of a fellowship from ”La Caixa” Foundation (ID 100010434), whose code is “LCF/BQ/DR23/12000020”. C.C. has received a fellowship from VHIR.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Garcia-Cehic, Damir
  • Campos, Carolina
  • Ibañez Lligoña, Marta
  • Colomer-Castell, Sergi
  • Gregori Font, Josep
  • Piñana, María
  • González-Sánchez, Alejandra
  • Rando Segura, Ariadna
  • Esperalba, Juliana
  • Saubi, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Ferrer Costa, Roser
  • Esteban Mur, Juan Ignacio
  • Pumarola Suñe, Tomàs
  • QUER, JOSEP
  • Antón Pagarolas, Andrés
  • Andrés Vergés, Cristina
Omicron; Deep‐sequencing; Dual evolution, Òmicron; Seqüenciació profunda; Evolució dual, Ómicron; Secuenciación profunda; Evolución dual, SARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by the Centro para el Desarrollo Tecnológico Industrial (CDTI) of the Spanish Ministry of Economy and Business, grant number IDI-20200297; Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe; Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness (grants FIS PI19/00301, PI19/00533, PI22/00258, PI22/00023, and PI23/01065); CIBER—Consorcio Centro de Investigación Biomédica en Red—(CIBERINFEC, ISCIII—CIBER of Infectious Diseases & CIBEREHD, ISCIII—CIBER of Hepatic and Digestive Diseases), Instituto de Salud Carlos III, Ministry of Science and Innovation and the European Union—NextGenerationEU. Research contributions of Wageningen Bioveterinary Research are funded from the ERRAZE (Early Response and Rapid Action Zoonotic Emergencies Program). C.C. received a predoctoral fellowship from the Vall d'Hebron Institute of Research (VHIR). M.I.-L. was supported by a fellowship from the “La Caixa” Foundation (ID 100010434), with code “LCF/BQ/DR23/12000020”. S.C-C. received support from the Spanish Ministry of Education grant FPU21/04150.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Campos, Carolina
  • Ibañez-Lligoña, Marta
  • Colomer‑Castell, Sergi
  • Gregori, Josep
  • Garcia‑Cehic, Damir
  • Andrés, Cristina
  • Piñana, Maria
  • González‑Sánchez, Alejandra
  • Rando‑Segura, Ariadna
  • Esperalba, Juliana
  • Saubí, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Rodriguez-Frias, Francisco
  • Ferrer, Roser
  • Esteban, Juan Ignacio
  • Kakze-van der Honing, Renate W.
  • Kampfraath, Andries A.
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • van der Poel, Wim H. M.
  • Pumarola, Tomàs
  • Antón, Andrés
  • Quer, Josep
SARS‐CoV‐2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep‐sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS‐CoV‐2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by Spanish Ministry of Education, Centro para el Desarrollo Tecnológico Industrial (CDTI), Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness, Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, 'la Caixa' Foundation, Consorcio Centro de Investigación Biomédica en Red (CIBER), and Early Response and Rapid Action Zoonotic Emergencies Program (ERRAZE)., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In-Host Flat-like Quasispecies, Characterization Methods and Clinical Implications

  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Colomer Castell, Sergi|||0000-0002-0307-7455
  • Ibañez Lligoña, Marta|||0000-0003-3428-2168
  • Garcia-Cehic, D.|||0000-0002-0009-038X
  • Campos, Carolina|||0000-0002-0132-7027
  • Buti, Maria|||0000-0002-0732-3078
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Andrés, Cristina|||0000-0002-3200-0895
  • Piñana, Maria|||0000-0002-4766-2613
  • González Sánchez, Alejandra|||0000-0002-1809-3415
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Cortese, Maria Francesca|||0000-0002-4318-532X
  • Tabernero, David|||0000-0002-1146-4084
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
  • Quer, Josep|||0000-0003-0014-084X
The repeated failure to treat patients chronically infected with hepatitis E (HEV) and C (HCV) viruses, despite the absence of resistance-associated substitutions (RAS), particularly in response to prolonged treatments with the mutagenic agents of HEV, suggests that quasispecies structure may play a crucial role beyond single point mutations. Quasispecies structured in a flat-like manner (referred to as flat-like) are considered to possess high average fitness, occupy a significant fraction of the functional genetic space of the virus, and exhibit a high capacity to evade specific or mutagenic treatments. In this paper, we studied HEV and HCV samples using high-depth next-generation sequencing (NGS), with indices scoring the different properties describing flat-like quasispecies. The significance of these indices was demonstrated by comparing the values obtained from these samples with those from acute infections caused by respiratory viruses (betacoronaviruses, enterovirus, respiratory syncytial viruses, and metapneumovirus). Our results revealed that flat-like quasispecies in HEV and HCV chronic infections without RAS are characterized by numerous low-frequency haplotypes with no dominant one. Surprisingly, these low-frequency haplotypes (at the nucleotide level) exhibited a high level of synonymity, resulting in much lower diversity at the phenotypic level. Currently, clinical approaches for managing flat-like quasispecies are lacking. Here, we propose methods to identifying flat-like quasispecies, which represents an essential initial step towards exploring alternative treatment protocols for viruses resistant to conventional therapies.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications

  • Gregori Font, Josep
  • Colomer-Castell, Sergi
  • Ibañez Lligoña, Marta
  • Garcia-Cehic, Damir
  • Campos, Carolina
  • Riveiro-Barciela, Mar
  • Piñana, María
  • González-Sánchez, Alejandra
  • RODRIGUEZ-FRIAS, FRANCISCO
  • Cortese, Maria Francesca
  • Tabernero, David
  • Rando Segura, Ariadna
  • Pumarola Suñe, Tomàs
  • Esteban Mur, Juan Ignacio
  • QUER, JOSEP
  • Buti Ferret, Maria
  • Antón Pagarolas, Andrés
  • Andrés Vergés, Cristina
Cuasiespecies; Mutágenos; Mutaciones, Quasispecies; Mutagens; Mutations, Quasiespècie; Mutàgens; Mutacions, The repeated failure to treat patients chronically infected with hepatitis E (HEV) and C (HCV) viruses, despite the absence of resistance-associated substitutions (RAS), particularly in response to prolonged treatments with the mutagenic agents of HEV, suggests that quasispecies structure may play a crucial role beyond single point mutations. Quasispecies structured in a flat-like manner (referred to as flat-like) are considered to possess high average fitness, occupy a significant fraction of the functional genetic space of the virus, and exhibit a high capacity to evade specific or mutagenic treatments. In this paper, we studied HEV and HCV samples using high-depth next-generation sequencing (NGS), with indices scoring the different properties describing flat-like quasispecies. The significance of these indices was demonstrated by comparing the values obtained from these samples with those from acute infections caused by respiratory viruses (betacoronaviruses, enterovirus, respiratory syncytial viruses, and metapneumovirus). Our results revealed that flat-like quasispecies in HEV and HCV chronic infections without RAS are characterized by numerous low-frequency haplotypes with no dominant one. Surprisingly, these low-frequency haplotypes (at the nucleotide level) exhibited a high level of synonymity, resulting in much lower diversity at the phenotypic level. Currently, clinical approaches for managing flat-like quasispecies are lacking. Here, we propose methods to identifying flat-like quasispecies, which represents an essential initial step towards exploring alternative treatment protocols for viruses resistant to conventional therapies., This study was partially supported by Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297; Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Fondo de Investigación Sanitaria, Ministerio Español de Economía y Competitividad (grants FIS PI19/00301, PI22/00258, PI22/00023 and PI23/01065); CIBER—Consorcio Centro de Investigación Biomédica en Red—(CIBERINFEC, ISCIII—CIBER de Enfermedades Infecciosas & CIBEREHD, ISCIII. CIBER de Enfermedades Hepáticas y Digestivas), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea—NextGenerationEU; S.C.-C received support from the Spanish Ministry of Education grant FPU21/04150. M.I.-L. received the support of a fellowship from ”La Caixa” Foundation (ID 100010434), whose code is “LCF/BQ/DR23/12000020”. C.C. has received a fellowship from VHIR.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Garcia-Cehic, Damir
  • Campos, Carolina
  • Ibañez Lligoña, Marta
  • Colomer-Castell, Sergi
  • Gregori Font, Josep
  • Piñana, María
  • González-Sánchez, Alejandra
  • Rando Segura, Ariadna
  • Esperalba, Juliana
  • Saubi, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Ferrer Costa, Roser
  • Esteban Mur, Juan Ignacio
  • Pumarola Suñe, Tomàs
  • QUER, JOSEP
  • Antón Pagarolas, Andrés
  • Andrés Vergés, Cristina
Omicron; Deep‐sequencing; Dual evolution, Òmicron; Seqüenciació profunda; Evolució dual, Ómicron; Secuenciación profunda; Evolución dual, SARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by the Centro para el Desarrollo Tecnológico Industrial (CDTI) of the Spanish Ministry of Economy and Business, grant number IDI-20200297; Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe; Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness (grants FIS PI19/00301, PI19/00533, PI22/00258, PI22/00023, and PI23/01065); CIBER—Consorcio Centro de Investigación Biomédica en Red—(CIBERINFEC, ISCIII—CIBER of Infectious Diseases & CIBEREHD, ISCIII—CIBER of Hepatic and Digestive Diseases), Instituto de Salud Carlos III, Ministry of Science and Innovation and the European Union—NextGenerationEU. Research contributions of Wageningen Bioveterinary Research are funded from the ERRAZE (Early Response and Rapid Action Zoonotic Emergencies Program). C.C. received a predoctoral fellowship from the Vall d'Hebron Institute of Research (VHIR). M.I.-L. was supported by a fellowship from the “La Caixa” Foundation (ID 100010434), with code “LCF/BQ/DR23/12000020”. S.C-C. received support from the Spanish Ministry of Education grant FPU21/04150.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence Conservation

  • Dopico, Eva
  • Vila Salvador, Marta
  • Pacin Ruiz, Beatriz
  • Pérez Garreta, Javier
  • Buti Ferret, Maria
  • Tabernero, David
  • Gregori Font, Josep
  • Rando Segura, Ariadna
  • QUER, JOSEP
  • González-Sánchez, Alejandra
  • Pumarola Suñe, Tomàs
  • Riveiro-Barciela, Mar
  • Ferrer Costa, Roser
  • RODRIGUEZ-FRIAS, FRANCISCO
  • Cortese, Maria Francesca
  • Antón Pagarolas, Andrés
RNA interference; Hepatitis B X gene; Next-generation sequencing, Interferència d'ARN; Gen de l'hepatitis BX; Seqüenciació de nova generació, Interferencia de ARN; Gen de la hepatitis BX; Secuenciación de nueva generación, Our aim was to develop an accurate, highly sensitive method for HBV genotype determination and detection of genotype mixtures. We examined the preS and 5' end of the HBV X gene (5X) regions of the HBV genome using next-generation sequencing (NGS). The 1852 haplotypes obtained were subjected to genotyping via the Distance-Based discrimination method (DB Rule) using two sets of 95 reference sequences of genotypes A-H. In clinical samples from 125 patients, the main genotypes were A, D, F and H in Caucasian, B and C in Asian and A and E in Sub-Saharan patients. Genotype mixtures were identified in 28 (22.40%) cases, and potential intergenotypic recombination was observed in 29 (23.20%) cases. Furthermore, we evaluated sequence conservation among haplotypes classified into genotypes A, C, D, and E by computing the information content. The preS haplotypes exhibited limited shared conserved regions, whereas the 5X haplotypes revealed two groups of conserved regions across the genotypes assessed. In conclusion, we developed an NGS-based HBV genotyping method utilizing the DB Rule for genotype classification. We identified two regions conserved across different genotypes at 5X, offering promising targets for RNA interference-based antiviral therapies., This research was funded by the grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297; Projects PI19/00301 and PI22/00258 funded by Instituto de Salud Carlos III (ISCIII) and cofounded by the European Union.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics

  • Garcia-Larroy, Jorgina
  • Antón Pagarolas, Andrés
  • Ibañez Lligoña, Marta
  • Colomer-Castell, Sergi
  • Campos, Carolina
  • González Camuesco, Álvaro
  • Llaurado, Arnau
  • Sánchez-Tejerina, Daniel
  • Rando Segura, Ariadna
  • Andrés Vergés, Cristina
  • Esperalba, Juliana
  • Nadal-Barón, Patricia
  • Ferrer Costa, Roser
  • Cortese, Maria Francesca
  • Tabernero, David
  • Gregori Font, Josep
  • Riveiro-Barciela, Mar
  • Ruiz Cobo, Juan Carlos
  • del Barco Martínez, Ester
  • Buti Ferret, Maria
  • Goya, Maria
  • Juntas Morales, Raúl
  • QUER, JOSEP
Coinfection; Ddiagnostics; Metagenomics, Coinfección; Diagnóstico; Metagenómica, Coinfecció; Diagnòstic; Metagenòmica, Introduction: Shotgun metagenomic sequencing (mNGS), an untargeted approach that sequences all nucleic acids in a sample, has emerged as a powerful tool for pathogen detection and genome characterization. However, its implementation in clinical diagnostics remains limited due to technical challenges such as contamination and reduces sensitivity, especially in low-biomass samples.Methods: We applied mNGS to 144 clinical samples representing chronic infections, acute infections, and respiratory co-infections. To address contamination, we established a framework integrating negative controls, lab-specific contaminant watchlists, and computational filtering. Viral detection performance and genome recovery were assessed across sample types and viral loads.Results: Viral load was shown to be the primary determinant of sensitivity, with reliable recovery achieved only at higher titers. Our framework substantially improved contamination management, reducing false-positive signals and enhancing viral genome recovery. mNGS enabled the detection of clinically relevant co-infections and refined viral classification beyond targeted diagnostics, while also revealing the substantial risk of spurious detections in the absence of contamination-aware workflows.Discussion: These findings define practical sensitivity thresholds for clinical mNGS and underscore the need for contamination-aware workflows, particularly for low-biomass samples, while providing an open-source contaminants watchlist that enhances reliability and utility of clinical metagenomics., The author(s) declared that financial support was received for this work and/or its publication. This study was partially supported by Grants PI22/00258, PI22/00023, and PI23/01065 funded by Instituto de Salud Carlos III (ISCIII), Grant PMPER24/00018 and PID2021-126447OB-I00 under the Ministry of Science, Innovation and Universities of Spain and cofounded by the European Union; and Consorcio Centro de Investigación Biomédica en Red CIBERINFEC and CIBEREHD. MI-L was supported by a fellowship from the “La Caixa” Foundation (ID 100010434) with code “LCF/BQ/DR23/12000020.” SC-C received support from the Spanish Ministry of Education grant FPU21/04150. CC received a predoctoral fellowship from Vall d’Hebron Institute of Research (VHIR).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments

  • Vico-Romero, Judit
  • Campos, Carolina
  • Cortese, Maria Francesca
  • Colomer-Castell, Sergi
  • Gregori Font, Josep
  • Garcia-Cehic, Damir
  • Riveiro-Barciela, Mar
  • Rando Segura, Ariadna
  • Ibañez Lligoña, Marta
  • ADOMBI, Caroline Mélanie
  • Tabernero, David
  • Esteban Mur, Juan Ignacio
  • RODRIGUEZ-FRIAS, FRANCISCO
  • QUER, JOSEP
  • Buti Ferret, Maria
Deep sequencing; Mutagens; Quasispecies, Seqüenciació profunda; Mutàgens; Quasiespècie, Secuenciación profunda; Mutágenos; Cuasiespecie, Here, we report the in-host hepatitis E virus (HEV) quasispecies evolution in a chronically infected patient who was treated with three different regimens of ribavirin (RBV) for nearly 6 years. Sequential plasma samples were collected at different time points and subjected to RNA extraction and deep sequencing using the MiSeq Illumina platforms. Specifically, we RT-PCR amplified a single amplicon from the core region located in the open-reading frame 2 (ORF2). At the nucleotide level (genotype), our analysis showed an increase in the number of rare haplotypes and a drastic reduction in the frequency of the master (most represented) sequence during the period when the virus was found to be insensitive to RBV treatment. Contrarily, at the amino acid level (phenotype), our study revealed conservation of the amino acids, which is represented by a high prevalence of the master sequence. Our findings suggest that using mutagenic antivirals concomitant with high viral loads can lead to the selection and proliferation of a rich set of synonymous haplotypes that express the same phenotype. This can also lead to the selection and proliferation of conservative substitutions that express fitness-enhanced phenotypes. These results have important clinical implications, as they suggest that using mutagenic agents as a monotherapy treatment regimen in the absence of sufficiently effective viral inhibitors can result in diversification and proliferation of a highly diverse quasispecies resistant to further treatment. Therefore, such approaches should be avoided whenever possible., This study was partially supported by Plan Estratègic de Recerca i Innovació en Salut (PERIS)—Direcció General de Recerca i Innovació en Salut (DGRIS), Catalan Health Ministry, Generalitat de Catalunya; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297, Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Projects PI19/00301 and PI22/00258 funded by Instituto de Salud Carlos III (ISCIII) and cofounded by the European Union; and Gilead’s biomedical research project GLD21/00006. S.C.-C has received support from Spanish Ministry of Education, grant FPU21/04150. M.I.-L. received the support of a fellowship from the “la Caixa” Foundation (ID 100010434), whose code is “LCF/BQ/DR23/12000020”.